Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 04:02:08 UTC |
---|
Update Date | 2021-09-26 23:00:28 UTC |
---|
HMDB ID | HMDB0249524 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Cabozantinib |
---|
Description | Cabozantinib, also known as BMS 907351 or XL 184, belongs to the class of organic compounds known as diarylethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are aryl groups. Based on a literature review a significant number of articles have been published on Cabozantinib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Cabozantinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Cabozantinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2 InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34) |
---|
Synonyms | Value | Source |
---|
BMS 907351 | ChEBI | BMS-907351 | ChEBI | XL 184 | ChEBI | XL-184 | ChEBI | XL184 | ChEBI | Cabometyx | Kegg | Cometriq | Kegg | XL184 CPD | MeSH | Cabozantinib | MeSH |
|
---|
Chemical Formula | C28H24FN3O5 |
---|
Average Molecular Weight | 501.514 |
---|
Monoisotopic Molecular Weight | 501.169999048 |
---|
IUPAC Name | N'1-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
---|
Traditional Name | cabozantinib |
---|
CAS Registry Number | Not Available |
---|
SMILES | COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2 |
---|
InChI Identifier | InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34) |
---|
InChI Key | ONIQOQHATWINJY-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as diarylethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are aryl groups. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Ethers |
---|
Direct Parent | Diarylethers |
---|
Alternative Parents | |
---|
Substituents | - Diaryl ether
- Quinoline
- Anilide
- Phenoxy compound
- Anisole
- Phenol ether
- N-arylamide
- Alkyl aryl ether
- Halobenzene
- Fluorobenzene
- Aryl fluoride
- Aryl halide
- Cyclopropanecarboxylic acid or derivatives
- Benzenoid
- Pyridine
- Monocyclic benzene moiety
- Heteroaromatic compound
- Carboxamide group
- Secondary carboxylic acid amide
- Azacycle
- Organoheterocyclic compound
- Carboxylic acid derivative
- Organopnictogen compound
- Carbonyl group
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organonitrogen compound
- Organofluoride
- Organohalogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Cabozantinib,1TMS,isomer #1 | COC1=CC2=NC=CC(OC3=CC=C(N(C(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)[Si](C)(C)C)C=C3)=C2C=C1OC | 4210.0 | Semi standard non polar | 33892256 | Cabozantinib,1TMS,isomer #1 | COC1=CC2=NC=CC(OC3=CC=C(N(C(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)[Si](C)(C)C)C=C3)=C2C=C1OC | 3949.5 | Standard non polar | 33892256 | Cabozantinib,1TMS,isomer #1 | COC1=CC2=NC=CC(OC3=CC=C(N(C(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)[Si](C)(C)C)C=C3)=C2C=C1OC | 5609.8 | Standard polar | 33892256 | Cabozantinib,1TMS,isomer #2 | COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(C(=O)N(C5=CC=C(F)C=C5)[Si](C)(C)C)CC4)C=C3)=C2C=C1OC | 4197.2 | Semi standard non polar | 33892256 | Cabozantinib,1TMS,isomer #2 | COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(C(=O)N(C5=CC=C(F)C=C5)[Si](C)(C)C)CC4)C=C3)=C2C=C1OC | 3932.4 | Standard non polar | 33892256 | Cabozantinib,1TMS,isomer #2 | COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(C(=O)N(C5=CC=C(F)C=C5)[Si](C)(C)C)CC4)C=C3)=C2C=C1OC | 5647.2 | Standard polar | 33892256 | Cabozantinib,2TMS,isomer #1 | COC1=CC2=NC=CC(OC3=CC=C(N(C(=O)C4(C(=O)N(C5=CC=C(F)C=C5)[Si](C)(C)C)CC4)[Si](C)(C)C)C=C3)=C2C=C1OC | 4023.3 | Semi standard non polar | 33892256 | Cabozantinib,2TMS,isomer #1 | COC1=CC2=NC=CC(OC3=CC=C(N(C(=O)C4(C(=O)N(C5=CC=C(F)C=C5)[Si](C)(C)C)CC4)[Si](C)(C)C)C=C3)=C2C=C1OC | 3649.7 | Standard non polar | 33892256 | Cabozantinib,2TMS,isomer #1 | COC1=CC2=NC=CC(OC3=CC=C(N(C(=O)C4(C(=O)N(C5=CC=C(F)C=C5)[Si](C)(C)C)CC4)[Si](C)(C)C)C=C3)=C2C=C1OC | 5093.9 | Standard polar | 33892256 | Cabozantinib,1TBDMS,isomer #1 | COC1=CC2=NC=CC(OC3=CC=C(N(C(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)[Si](C)(C)C(C)(C)C)C=C3)=C2C=C1OC | 4450.5 | Semi standard non polar | 33892256 | Cabozantinib,1TBDMS,isomer #1 | COC1=CC2=NC=CC(OC3=CC=C(N(C(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)[Si](C)(C)C(C)(C)C)C=C3)=C2C=C1OC | 4123.0 | Standard non polar | 33892256 | Cabozantinib,1TBDMS,isomer #1 | COC1=CC2=NC=CC(OC3=CC=C(N(C(=O)C4(C(=O)NC5=CC=C(F)C=C5)CC4)[Si](C)(C)C(C)(C)C)C=C3)=C2C=C1OC | 5561.8 | Standard polar | 33892256 | Cabozantinib,1TBDMS,isomer #2 | COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(C(=O)N(C5=CC=C(F)C=C5)[Si](C)(C)C(C)(C)C)CC4)C=C3)=C2C=C1OC | 4441.5 | Semi standard non polar | 33892256 | Cabozantinib,1TBDMS,isomer #2 | COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(C(=O)N(C5=CC=C(F)C=C5)[Si](C)(C)C(C)(C)C)CC4)C=C3)=C2C=C1OC | 4096.1 | Standard non polar | 33892256 | Cabozantinib,1TBDMS,isomer #2 | COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(C(=O)N(C5=CC=C(F)C=C5)[Si](C)(C)C(C)(C)C)CC4)C=C3)=C2C=C1OC | 5595.1 | Standard polar | 33892256 | Cabozantinib,2TBDMS,isomer #1 | COC1=CC2=NC=CC(OC3=CC=C(N(C(=O)C4(C(=O)N(C5=CC=C(F)C=C5)[Si](C)(C)C(C)(C)C)CC4)[Si](C)(C)C(C)(C)C)C=C3)=C2C=C1OC | 4466.1 | Semi standard non polar | 33892256 | Cabozantinib,2TBDMS,isomer #1 | COC1=CC2=NC=CC(OC3=CC=C(N(C(=O)C4(C(=O)N(C5=CC=C(F)C=C5)[Si](C)(C)C(C)(C)C)CC4)[Si](C)(C)C(C)(C)C)C=C3)=C2C=C1OC | 4013.2 | Standard non polar | 33892256 | Cabozantinib,2TBDMS,isomer #1 | COC1=CC2=NC=CC(OC3=CC=C(N(C(=O)C4(C(=O)N(C5=CC=C(F)C=C5)[Si](C)(C)C(C)(C)C)CC4)[Si](C)(C)C(C)(C)C)C=C3)=C2C=C1OC | 5104.5 | Standard polar | 33892256 |
|
---|
| MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Cabozantinib , positive-QTOF | splash10-0udi-0139180000-20096332e7e989d72392 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cabozantinib 10V, Positive-QTOF | splash10-0udi-0043190000-2ad3469c3893b52f7b60 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cabozantinib 20V, Positive-QTOF | splash10-0a4l-1297110000-e8677723550139710091 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cabozantinib 40V, Positive-QTOF | splash10-014i-9201000000-6b8e6247232b7eada9d0 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cabozantinib 10V, Negative-QTOF | splash10-0udi-0413190000-a7785d888ed69543a145 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cabozantinib 20V, Negative-QTOF | splash10-01tj-6819100000-068fb3a8dd9252ac2d08 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cabozantinib 40V, Negative-QTOF | splash10-06rm-7927000000-6d2b6684eb0a04dce7b2 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cabozantinib 10V, Positive-QTOF | splash10-0udi-0001090000-732b2f126b6a5737b840 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cabozantinib 20V, Positive-QTOF | splash10-016r-3907010000-3948adea7d9c2acde5ed | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cabozantinib 40V, Positive-QTOF | splash10-00kg-9216110000-54272d197a5b4624dec6 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cabozantinib 10V, Negative-QTOF | splash10-0udi-0101090000-371cf0abc0d379848615 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cabozantinib 20V, Negative-QTOF | splash10-0imj-0905320000-8a1e7cec7512e16579f2 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cabozantinib 40V, Negative-QTOF | splash10-01ta-0912200000-f8177c85dcf63e875fbb | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|